Qianwen Shao

Jiangsu Province Hospital Guangzhou Road 300
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Tislelizumab Induced Vitiligo-Like Depigmentation in a Chinese Patient with Oesophageal Squamous Cell Carcinoma.

Tislelizumab Induced Vitiligo-Like Depigmentation in a Chinese Patient with Oesophageal Squamous Cell Carcinoma.

Journal: Indian journal of dermatology

Published: March 31, 2023

Case report: Bullous pemphigoid associated with sintilimab therapy for pMMR/MSS colorectal cancer.

Case report: Bullous pemphigoid associated with sintilimab therapy for pMMR/MSS colorectal cancer.

Journal: Frontiers in oncology

Published: January 18, 2023

A lung adenocarcinoma patient with ROS1 fusion and NBN germline mutation achieves long progression-free survival from sintilimab combined with niraparib after failure of ROS1 inhibitors: a case report.

A lung adenocarcinoma patient with ROS1 fusion and NBN germline mutation achieves long progression-free survival from sintilimab combined with niraparib after failure of ROS1 inhibitors: a case report.

Journal: Annals of translational medicine

Published: May 16, 2022

Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study.

Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study.

Journal: Frontiers in oncology

Published: March 31, 2022

Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial.

Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial.

Journal: Journal for immunotherapy of cancer

Published: September 29, 2020

SNHG 6 promotes the progression of Colon and Rectal adenocarcinoma via miR-101-3p and Wnt/β-catenin signaling pathway.

SNHG 6 promotes the progression of Colon and Rectal adenocarcinoma via miR-101-3p and Wnt/β-catenin signaling pathway.

Journal: BMC gastroenterology

Published: July 30, 2019

The expressions of YAP1, β-catenin and survivin in colon cancer tissues and their clinical significance.

The expressions of YAP1, β-catenin and survivin in colon cancer tissues and their clinical significance.

Journal: International journal of clinical and experimental pathology

Published: October 16, 2018

In vitro and in vivo effects of miRNA-19b/20a/92a on gastric cancer stem cells and the related mechanism.

In vitro and in vivo effects of miRNA-19b/20a/92a on gastric cancer stem cells and the related mechanism.

Journal: International journal of medical sciences

Published: May 24, 2017

A systematic analysis of predicted MiR-31-targets identifies a diagnostic and prognostic signature for lung cancer.

A systematic analysis of predicted MiR-31-targets identifies a diagnostic and prognostic signature for lung cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 21, 2014

Bone marrow cells: Important role on neovascularization of hepatocellular carcinoma.

Bone marrow cells: Important role on neovascularization of hepatocellular carcinoma.

Journal: Journal of gastroenterology and hepatology

Published: December 07, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026